Stocks and Investing Stocks and Investing
Wed, June 26, 2024
Tue, June 25, 2024

David Lebovitz Maintained (ALNY) at Strong Buy with Increased Target to $291 on, Jun 25th, 2024


Published on 2024-10-28 12:05:51 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Citigroup, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $227 to $291 on, Jun 25th, 2024.

David has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with David


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $275 on, Monday, June 24th, 2024
  • Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Monday, June 24th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Monday, June 24th, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $283 on, Friday, June 21st, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024
Contributing Sources